CervoMed Inc. (CRVO) vs Kyntra Bio, Inc. (KYNB)
A side-by-side comparison of CervoMed Inc. and Kyntra Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVO
CervoMed Inc.
$3.24HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT
KYNB
Kyntra Bio, Inc.
$5.91HealthcareDelayed quote: Oct 6, 2026, 1:02 PM EDT
Total return — CRVO vs KYNB
growth of $100 · dividends reinvested · last 10yCRVO -100.0% (-54.0%/yr)KYNB -98.8% (-35.7%/yr)KYNB compounded faster over this window
Log scale — wide-divergence pair
CRVO KYNB
CRVO vs KYNB: by the numbers
- •CRVO is the larger company ($30M vs $24M market cap).
- •KYNB is profitable (3967.77% net margin) while CRVO runs a net loss (-9408.76%).
Metrics side by side
Valuation
| Metric | CRVO | KYNB |
|---|---|---|
| P/S ratio | 93.00 | 5.18 |
| P/B ratio | 1.31 | N/A |
Profitability
| Metric | CRVO | KYNB |
|---|---|---|
| Gross margin | 0.00% | 91.37% |
| Operating margin | 0.00% | -712.66% |
| Net margin | -9408.76% | 3967.77% |
| ROE | -132.18% | N/A |
| ROIC | -135.73% | -78.16% |
Growth (annualized)
| Metric | CRVO | KYNB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -51.49% |
| Total return CAGR (5Y) | -38.25% | -52.67% |
Frequently asked
- Is CRVO or KYNB more profitable?
- KYNB runs the higher net margin — CRVO at -9408.76% versus KYNB at 3967.77%.
- How have CRVO and KYNB total returns compared?
- Over the past 10 years, CRVO delivered -53.96% and KYNB delivered -35.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.